Format
Sort by
Items per page

Send to

Choose Destination

Best matches for López CB[au]:

Search results

Items: 1 to 50 of 58

1.

Defective (interfering) viral genomes re-explored: impact on antiviral immunity and virus persistence.

Manzoni TB, López CB.

Future Virol. 2018 Jul;13(7):493-503. doi: 10.2217/fvl-2018-0021. Epub 2018 Jun 12. Review.

2.

Sterols of the Toxic Marine Dinoflagellate, Pyrodinium bahamense.

Houle HM, Lopez CB, Leblond JD.

J Eukaryot Microbiol. 2018 Aug 18. doi: 10.1111/jeu.12684. [Epub ahead of print]

PMID:
30120793
3.

Virus-derived immunostimulatory RNA induces type I IFN-dependent antibodies and T-cell responses during vaccination.

Fisher DG, Coppock GM, López CB.

Vaccine. 2018 Jun 27;36(28):4039-4045. doi: 10.1016/j.vaccine.2018.05.100. Epub 2018 May 31.

PMID:
29861183
4.

Impact of pathological features of brain metastases in prognosis.

Castaneda CA, Castillo M, Bernabe LA, Sanchez J, Casavilca S, García-Corrochano P, Ponce J, Villa-Robles MR, Lopez CB, Orrego E.

Biomark Med. 2018 May;12(5):475-485. doi: 10.2217/bmm-2017-0161. Epub 2018 Apr 26.

PMID:
29697273
5.

Replication defective viral genomes exploit a cellular pro-survival mechanism to establish paramyxovirus persistence.

Xu J, Sun Y, Li Y, Ruthel G, Weiss SR, Raj A, Beiting D, López CB.

Nat Commun. 2017 Oct 6;8(1):799. doi: 10.1038/s41467-017-00909-6.

6.

Human Genetic Determinants of Viral Diseases.

Kenney AD, Dowdle JA, Bozzacco L, McMichael TM, St Gelais C, Panfil AR, Sun Y, Schlesinger LS, Anderson MZ, Green PL, López CB, Rosenberg BR, Wu L, Yount JS.

Annu Rev Genet. 2017 Nov 27;51:241-263. doi: 10.1146/annurev-genet-120116-023425. Epub 2017 Aug 30. Review.

PMID:
28853921
7.

IL-27 Limits Type 2 Immunopathology Following Parainfluenza Virus Infection.

Muallem G, Wagage S, Sun Y, DeLong JH, Valenzuela A, Christian DA, Harms Pritchard G, Fang Q, Buza EL, Jain D, Elloso MM, López CB, Hunter CA.

PLoS Pathog. 2017 Jan 27;13(1):e1006173. doi: 10.1371/journal.ppat.1006173. eCollection 2017 Jan.

8.

Activity of Uncleaved Caspase-8 Controls Anti-bacterial Immune Defense and TLR-Induced Cytokine Production Independent of Cell Death.

Philip NH, DeLaney A, Peterson LW, Santos-Marrero M, Grier JT, Sun Y, Wynosky-Dolfi MA, Zwack EE, Hu B, Olsen TM, Rongvaux A, Pope SD, López CB, Oberst A, Beiting DP, Henao-Mejia J, Brodsky IE.

PLoS Pathog. 2016 Oct 13;12(10):e1005910. doi: 10.1371/journal.ppat.1005910. eCollection 2016 Oct.

9.

The innate immune response to RSV: Advances in our understanding of critical viral and host factors.

Sun Y, López CB.

Vaccine. 2017 Jan 11;35(3):481-488. doi: 10.1016/j.vaccine.2016.09.030. Epub 2016 Sep 28. Review.

10.

RIPK3 Activates Parallel Pathways of MLKL-Driven Necroptosis and FADD-Mediated Apoptosis to Protect against Influenza A Virus.

Nogusa S, Thapa RJ, Dillon CP, Liedmann S, Oguin TH 3rd, Ingram JP, Rodriguez DA, Kosoff R, Sharma S, Sturm O, Verbist K, Gough PJ, Bertin J, Hartmann BM, Sealfon SC, Kaiser WJ, Mocarski ES, López CB, Thomas PG, Oberst A, Green DR, Balachandran S.

Cell Host Microbe. 2016 Jul 13;20(1):13-24. doi: 10.1016/j.chom.2016.05.011. Epub 2016 Jun 16.

11.

Respiratory Syncytial Virus Infection in Mice and Detection of Viral Genomes in the Lung Using RT-qPCR.

Sun Y, López CB.

Bio Protoc. 2016 May 20;6(10). pii: e1819. doi: 10.21769/BioProtoc.1819.

12.
13.

lncRHOXF1, a Long Noncoding RNA from the X Chromosome That Suppresses Viral Response Genes during Development of the Early Human Placenta.

Penkala I, Wang J, Syrett CM, Goetzl L, López CB, Anguera MC.

Mol Cell Biol. 2016 May 31;36(12):1764-75. doi: 10.1128/MCB.01098-15. Print 2016 Jun 15.

14.

Propagation and Characterization of Influenza Virus Stocks That Lack High Levels of Defective Viral Genomes and Hemagglutinin Mutations.

Xue J, Chambers BS, Hensley SE, López CB.

Front Microbiol. 2016 Mar 23;7:326. doi: 10.3389/fmicb.2016.00326. eCollection 2016.

15.

Identification of a Natural Viral RNA Motif That Optimizes Sensing of Viral RNA by RIG-I.

Xu J, Mercado-López X, Grier JT, Kim WK, Chun LF, Irvine EB, Del Toro Duany Y, Kell A, Hur S, Gale M Jr, Raj A, López CB.

MBio. 2015 Oct 6;6(5):e01265-15. doi: 10.1128/mBio.01265-15.

16.

Immunostimulatory Defective Viral Genomes from Respiratory Syncytial Virus Promote a Strong Innate Antiviral Response during Infection in Mice and Humans.

Sun Y, Jain D, Koziol-White CJ, Genoyer E, Gilbert M, Tapia K, Panettieri RA Jr, Hodinka RL, López CB.

PLoS Pathog. 2015 Sep 3;11(9):e1005122. doi: 10.1371/journal.ppat.1005122. eCollection 2015 Sep.

17.

In Vivo RNAi Screening Identifies MDA5 as a Significant Contributor to the Cellular Defense against Influenza A Virus.

Benitez AA, Panis M, Xue J, Varble A, Shim JV, Frick AL, López CB, Sachs D, tenOever BR.

Cell Rep. 2015 Jun 23;11(11):1714-26. doi: 10.1016/j.celrep.2015.05.032. Epub 2015 Jun 11.

18.

Defective viral genomes: critical danger signals of viral infections.

López CB.

J Virol. 2014 Aug;88(16):8720-3. doi: 10.1128/JVI.00707-14. Epub 2014 May 28. Review.

19.

Deficiency of melanoma differentiation-associated protein 5 results in exacerbated chronic postviral lung inflammation.

Kim WK, Jain D, Sánchez MD, Koziol-White CJ, Matthews K, Ge MQ, Haczku A, Panettieri RA Jr, Frieman MB, López CB.

Am J Respir Crit Care Med. 2014 Feb 15;189(4):437-48. doi: 10.1164/rccm.201307-1338OC.

20.

Defective viral genomes arising in vivo provide critical danger signals for the triggering of lung antiviral immunity.

Tapia K, Kim WK, Sun Y, Mercado-López X, Dunay E, Wise M, Adu M, López CB.

PLoS Pathog. 2013 Oct;9(10):e1003703. doi: 10.1371/journal.ppat.1003703. Epub 2013 Oct 31.

21.

Highly immunostimulatory RNA derived from a Sendai virus defective viral genome.

Mercado-López X, Cotter CR, Kim WK, Sun Y, Muñoz L, Tapia K, López CB.

Vaccine. 2013 Nov 19;31(48):5713-21. doi: 10.1016/j.vaccine.2013.09.040. Epub 2013 Oct 5.

22.

Granulocyte colony-stimulating factor protects mice during respiratory virus infections.

Hermesh T, Moran TM, Jain D, López CB.

PLoS One. 2012;7(5):e37334. doi: 10.1371/journal.pone.0037334. Epub 2012 May 16.

23.

Virus budding/host interactions.

Harty RN, Schmitt AP, Bouamr F, Lopez CB, Krummenacher C.

Adv Virol. 2011;2011:963192. doi: 10.1155/2011/963192. Epub 2011 Oct 20. No abstract available.

24.

Buying time-the immune system determinants of the incubation period to respiratory viruses.

Hermesh T, Moltedo B, López CB, Moran TM.

Viruses. 2010 Nov;2(11):2541-58. doi: 10.3390/v2112541. Epub 2010 Nov 18.

25.

The virion host shutoff protein of herpes simplex virus 1 blocks the replication-independent activation of NF-κB in dendritic cells in the absence of type I interferon signaling.

Cotter CR, Kim WK, Nguyen ML, Yount JS, López CB, Blaho JA, Moran TM.

J Virol. 2011 Dec;85(23):12662-72. doi: 10.1128/JVI.05557-11. Epub 2011 Sep 21.

26.

Systemic responses during local viral infections: type I IFNs sound the alarm.

López CB, Hermesh T.

Curr Opin Immunol. 2011 Aug;23(4):495-9. doi: 10.1016/j.coi.2011.06.003. Epub 2011 Jul 13. Review.

27.

Proapoptotic and antiapoptotic actions of Stat1 versus Stat3 underlie neuroprotective and immunoregulatory functions of IL-11.

Zhang J, Zhang Y, Dutta DJ, Argaw AT, Bonnamain V, Seto J, Braun DA, Zameer A, Hayot F, Lòpez CB, Raine CS, John GR.

J Immunol. 2011 Aug 1;187(3):1129-41. doi: 10.4049/jimmunol.1004066. Epub 2011 Jun 27.

28.

Ebolavirus VP35 suppresses IFN production from conventional but not plasmacytoid dendritic cells.

Leung LW, Park MS, Martinez O, Valmas C, López CB, Basler CF.

Immunol Cell Biol. 2011 Oct;89(7):792-802. doi: 10.1038/icb.2010.169. Epub 2011 Jan 25.

29.

Palmitoylome profiling reveals S-palmitoylation-dependent antiviral activity of IFITM3.

Yount JS, Moltedo B, Yang YY, Charron G, Moran TM, López CB, Hang HC.

Nat Chem Biol. 2010 Aug;6(8):610-4. doi: 10.1038/nchembio.405. Epub 2010 Jul 4.

30.

Antiviral instruction of bone marrow leukocytes during respiratory viral infections.

Hermesh T, Moltedo B, Moran TM, López CB.

Cell Host Microbe. 2010 May 20;7(5):343-53. doi: 10.1016/j.chom.2010.04.006.

31.

The virion host shut-off (vhs) protein blocks a TLR-independent pathway of herpes simplex virus type 1 recognition in human and mouse dendritic cells.

Cotter CR, Nguyen ML, Yount JS, López CB, Blaho JA, Moran TM.

PLoS One. 2010 Feb 18;5(2):e8684. doi: 10.1371/journal.pone.0008684.

32.

Subchronic toxicological evaluation of brea gum (Parkinsonia preacox) as a food additive in BALB/c mice.

von Müller AR, López CB, Eynard AR, Guzmán CA.

Drug Chem Toxicol. 2009;32(4):307-11. doi: 10.1080/01480540902976903.

PMID:
19793021
33.

IL-11 regulates autoimmune demyelination.

Gurfein BT, Zhang Y, López CB, Argaw AT, Zameer A, Moran TM, John GR.

J Immunol. 2009 Oct 1;183(7):4229-40. doi: 10.4049/jimmunol.0900622. Epub 2009 Sep 4.

34.

Cutting edge: stealth influenza virus replication precedes the initiation of adaptive immunity.

Moltedo B, López CB, Pazos M, Becker MI, Hermesh T, Moran TM.

J Immunol. 2009 Sep 15;183(6):3569-73. doi: 10.4049/jimmunol.0900091. Epub 2009 Aug 28.

35.

Estrogen inhibits dendritic cell maturation to RNA viruses.

Escribese MM, Kraus T, Rhee E, Fernandez-Sesma A, López CB, Moran TM.

Blood. 2008 Dec 1;112(12):4574-84. doi: 10.1182/blood-2008-04-148692. Epub 2008 Sep 18.

37.

Cytokine-independent upregulation of MDA5 in viral infection.

Yount JS, Moran TM, López CB.

J Virol. 2007 Jul;81(13):7316-9. Epub 2007 May 2. Erratum in: J Virol. 2007 Sep;81(17):9609.

38.

Protease-activated receptor 2 sensitizes the transient receptor potential vanilloid 4 ion channel to cause mechanical hyperalgesia in mice.

Grant AD, Cottrell GS, Amadesi S, Trevisani M, Nicoletti P, Materazzi S, Altier C, Cenac N, Zamponi GW, Bautista-Cruz F, Lopez CB, Joseph EK, Levine JD, Liedtke W, Vanner S, Vergnolle N, Geppetti P, Bunnett NW.

J Physiol. 2007 Feb 1;578(Pt 3):715-33. Epub 2006 Nov 23.

39.

A novel role for viral-defective interfering particles in enhancing dendritic cell maturation.

Yount JS, Kraus TA, Horvath CM, Moran TM, López CB.

J Immunol. 2006 Oct 1;177(7):4503-13.

40.

Sendai virus infection induces efficient adaptive immunity independently of type I interferons.

López CB, Yount JS, Hermesh T, Moran TM.

J Virol. 2006 May;80(9):4538-45.

41.

Toll-like receptor-independent triggering of dendritic cell maturation by viruses.

López CB, Yount JS, Moran TM.

J Virol. 2006 Apr;80(7):3128-34. Review. No abstract available.

42.

Intensified and protective CD4+ T cell immunity in mice with anti-dendritic cell HIV gag fusion antibody vaccine.

Trumpfheller C, Finke JS, López CB, Moran TM, Moltedo B, Soares H, Huang Y, Schlesinger SJ, Park CG, Nussenzweig MC, Granelli-Piperno A, Steinman RM.

J Exp Med. 2006 Mar 20;203(3):607-17. Epub 2006 Feb 27.

43.

TLR-independent induction of dendritic cell maturation and adaptive immunity by negative-strand RNA viruses.

López CB, Moltedo B, Alexopoulou L, Bonifaz L, Flavell RA, Moran TM.

J Immunol. 2004 Dec 1;173(11):6882-9.

44.

Stable metal isotopes reveal copper accumulation and loss dynamics in the freshwater bivalve Corbicula.

Croteau MN, Luoma SN, Topping BR, Lopez CB.

Environ Sci Technol. 2004 Oct 1;38(19):5002-9.

PMID:
15506192
45.

Characterization and distribution of colonic dendritic cells in Crohn's disease.

Silva MA, López CB, Riverin F, Oligny L, Menezes J, Seidman EG.

Inflamm Bowel Dis. 2004 Sep;10(5):504-12.

PMID:
15472509
47.

Type I interferon induction pathway, but not released interferon, participates in the maturation of dendritic cells induced by negative-strand RNA viruses.

López CB, García-Sastre A, Williams BR, Moran TM.

J Infect Dis. 2003 Apr 1;187(7):1126-36. Epub 2003 Mar 19.

PMID:
12660927
48.

Antiviral immunity and the role of dendritic cells.

López CB, Moran TM, Schulman JL, Fernandez-Sesma A.

Int Rev Immunol. 2002 Jul-Oct;21(4-5):339-53. Review.

PMID:
12486818
49.

Myeloid dendritic cells stimulate both Th1 and Th2 immune responses depending on the nature of the antigen.

López CB, Fernandez-Sesma A, Schulman JL, Moran TM.

J Interferon Cytokine Res. 2001 Sep;21(9):763-73.

PMID:
11576470
50.

A mouse model for immunization with ex vivo virus-infected dendritic cells.

López CB, Fernandez-Sesma A, Czelusniak SM, Schulman JL, Moran TM.

Cell Immunol. 2000 Dec 15;206(2):107-15.

PMID:
11161442

Supplemental Content

Loading ...
Support Center